Q2 2026 13F · SEC CIK 1973323
Foresight Global Investors, Inc.
Institutional asset managerFiled 2026-08-11 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $165.0M
- Reported positions
- 32
- Top holdings a year, 3 yrs
- +13.5%
- Assets under management
- $955.2M
Foresight Global Investors, Inc. is an institutional asset manager that reported 32 positions worth $165.0M in its Q2 2026 13F, filed 2026-08-11. Its largest holdings were Novartis AG (NVS, 14.6%), Astrazeneca PLC (AZN, 13.7%), Hsbc Hldgs PLC (HSBC, 12.3%). A portfolio copying its top holdings returned 13.5% a year over the last 3 years, against 20.4% for the S&P 500.
Foresight Global Investors, Inc. holdings all 32 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
What Foresight Global Investors, Inc. bought and sold in Q2 2026, against Q1 2026.
New positions
- AZN Astrazeneca PLC13.7% of 13F
- DB Deutsche Bk AG9.0% of 13F
- ALC Alcon Inc7.1% of 13F
- ABT Abbott Laboratories0.2% of 13F
- GDX Vaneck ETF Trust0.2% of 13F
Added to
- SONY Sony Group Corp+81.9% shares
- RTO Rentokil Initial PLC+17.0% shares
- EL Lauder Estee Cos Inc+7.3% shares
Reduced
- STLA Stellantis N.v-95.4% shares
- STM Stmicroelectronics N V Ny Registry-62.7% shares
- SDRL Seadrill Ltd-41.3% shares
- RIO Rio Tinto PLC-35.2% shares
- NVO Novo-Nordisk A S-31.0% shares
- NVS Novartis AG-10.7% shares
- CASY Caseys Gen Stores Inc-5.1% shares
Sold out
- AZN Astrazeneca Plcwas 18.6%
- IQV Iqvia Hldgs Incwas 0.2%
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- +20.4% /yr
- S&P 500 +20.1%
- 3 years
- +13.5% /yr
- S&P 500 +20.4%
- 5 years
- —
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $165.0M | 32 |
| Q1 2026 | $154.0M | 29 |
| Q4 2025 | $212.5M | 27 |
| Q3 2025 | $168.4M | 33 |
| Q2 2025 | $140.8M | 11 |
| Q1 2025 | $142.2M | 12 |
| Q4 2024 | $136.9M | 12 |
| Q3 2024 | $184.4M | 45 |
| Q2 2024 | $208.0M | 41 |
| Q1 2024 | $203.1M | 39 |
| Q4 2023 | $174.4M | 39 |
| Q3 2023 | $179.7M | 41 |
Questions about Foresight Global Investors, Inc.'s portfolio
What stocks does Foresight Global Investors, Inc. own?
Foresight Global Investors, Inc.'s latest 13F, for Q2 2026 and filed Aug 11, 2026, lists 32 positions worth $165.0M. The largest are Novartis AG (NVS) at 14.6%, Astrazeneca PLC (AZN) at 13.7%, Hsbc Hldgs PLC (HSBC) at 12.3%, Sony Group Corp (SONY) at 9.0% and Deutsche Bk AG (DB) at 9.0%.
What did Foresight Global Investors, Inc. buy last quarter?
In Q2 2026, Foresight Global Investors, Inc. added a new position in Astrazeneca PLC (AZN), a new position in Deutsche Bk AG (DB), a new position in Alcon Inc (ALC), a new position in Abbott Laboratories (ABT), a new position in Vaneck ETF Trust (GDX), Sony Group Corp (SONY) (+81.9% shares), Rentokil Initial PLC (RTO) (+17.0% shares) and Lauder Estee Cos Inc (EL) (+7.3% shares), compared with its Q1 2026 filing.
What did Foresight Global Investors, Inc. sell last quarter?
In Q2 2026, Foresight Global Investors, Inc. sold all of Astrazeneca Plc (AZN), sold all of Iqvia Hldgs Inc (IQV), Stellantis N.v (STLA) (-95.4% shares), Stmicroelectronics N V Ny Registry (STM) (-62.7% shares) and Seadrill Ltd (SDRL) (-41.3% shares), compared with its Q1 2026 filing.
How has Foresight Global Investors, Inc.'s portfolio performed?
A portfolio copying Foresight Global Investors, Inc.'s 20 largest 13F holdings each quarter, from the day each filing was public, returned +13.5% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +20.4% against +20.1%.
When is Foresight Global Investors, Inc.'s next 13F filing due?
13F filings are due 45 days after each quarter ends. Foresight Global Investors, Inc.'s filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does Foresight Global Investors, Inc. manage?
Foresight Global Investors, Inc. reported $955.2M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $165.0M.